Results 1 to 10 of about 17,452 (202)

Pulmonary tumor thrombotic microangiopathy presenting as recurrent syncope

SAGE Open Medical Case Reports, 2020
Pulmonary tumor thrombotic microangiopathy is a rare condition in which embolization of tumor cells to the pulmonary arterioles causes fibrocellular intimal thickening and activation of the coagulation cascade resulting in pulmonary hypertension and ...
Constanza Burciaga Calderoni, Dafne T Moretta, Jeanette Merrill-Henry, Paresh C Giri   +3 more
doaj   +1 more source

Association of thrombotic microangiopathy with interferon therapy for hepatitis B: a case report

Journal of Medical Case Reports
Background Thrombotic microangiopathy is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ injury. The pathological features include vascular damage that is manifested by arteriolar and capillary thrombosis with ...
Shan Wei, Wenjuan Mei, Ying Wang
doaj   +1 more source

Case of catastrophic antiphospholipid syndrome presenting as neuroretinitis and vaso-occlusive retinopathy

BMC Ophthalmology, 2020
Background Ocular involvement in catastrophic antiphospholipid syndrome (CAPS), a rare, life-threatening form of antiphospholipid syndrome (APS) that results in multiorgan failure and a high mortality rate, has rarely been reported.
Young In Yun, Ji Hyun Kim, Seon Hee Lim, Yo Han Ahn, Hee Gyung Kang, Il-Soo Ha, Baek-Lok Oh   +6 more
doaj   +1 more source

Severe Vitamin B12 Deficiency in Pregnancy Mimicking HELLP Syndrome

Case Reports in Obstetrics and Gynecology, 2019
Severe vitamin B12 deficiency may present with hematologic abnormalities that mimic thrombotic microangiopathy disorders such as hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome. We report a patient diagnosed with severe vitamin
Shravya Govindappagari, Michelle Nguyen, Megha Gupta, Ramy M. Hanna, Richard M. Burwick   +4 more
doaj   +1 more source

Clinical case of thrombotic microangiopathy in obstetric practice

Сеченовский вестник, 2017
Trombotic microangiopathy is heterogeneous group of the diseases united by a community of a histological and clinical implications at difference of pathogenetic mechanisms, presents clinical-morphological syndrome characterizing a lesion of vessels of a ...
M. N. Mochalova, T. E. Belokrinitskaya, T. V. Haven, E. M. Shifman, K. G. Shapovalov, S. V. Kostromitin   +5 more
doaj  

Ravulizumab in atypical hemolytic-uremic syndrome: a case report in a young woman with renal failure [PDF]

Pharmacia
Atypical hemolytic-uremic syndrome (aHUS) is a rare, life-threatening, complement-mediated thrombotic microangiopathy characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury.
Georgi Nikolov, Dimitar Nikolov, Violeta Zheleva, Spas Kitov, Maria-Florance Kitova, Anna A. Mihaylova, Lyudmila Kitova   +6 more
doaj   +3 more sources

Thrombotic microangiopathies: An update

Hematology, 2006
Thrombotic microangiopathies (TMA) are microvascular occlusive disorders characterized by hemolytic anemia caused by fragmentation of erythrocytes and thrombocytopenia due to increased platelet aggregation and thrombus formation, eventually leading to disturbed microcirculation with reduced organ perfusion.
openaire   +2 more sources

Thrombotic Microangiopathy [PDF]

BMJ, 1954
R D, REVILL, W C, WILSON
openaire   +2 more sources

Thrombotic microangiopathy associated with calcineurin inhibitor induction doses in patients with a kidney transplant

Clinical Case Reports
Key Clinical Message We present a case of a 23‐year‐old male who developed thrombotic microangiopathy associated with the induction dose of tacrolimus. Get an early diagnosis and give timely treatment of thrombotic microangiopathy is essential to improve
Alfredo Gutiérrez‐Govea, Basilio Jalomo‐Martínez, Luis Alberto Evangelista‐Carrillo, José Ignacio Cerrillos‐Gutiérrez, Miguel Medina‐Pérez   +4 more
doaj   +1 more source

The Use of Eculizumab in Tacrolimus-Induced Thrombotic Microangiopathy

Journal of Investigative Medicine High Impact Case Reports, 2020
Drug-induced thrombotic microangiopathy (DITMA) is a secondary cause of thrombotic microangiopathy and a potentially fatal inflammatory disease. DITMA has been attributed to a variety of drugs, particularly chemotherapeutic and immunosuppressive agents ...
Jihad Ben Gabr MD, Hiba Bilal MD, Kanish Mirchia MD, Andras Perl MD, PhD   +3 more
doaj   +1 more source